![]() | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About | ![]() |
Bone Loss in Women with Anorexia Nervosa
This study is currently recruiting patients.
Sponsored by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
---|---|
Information provided by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Purpose
Women with Anorexia Nervosa have been found to have low bone density. The study will determine whether administration of low doses of a natural hormone, testosterone and/or risedronate, a medication to help prevent bone breakdown will improve or prevent bone loss in this condition.
Condition | Treatment or Intervention |
---|---|
Anorexia Nervosa |
Drug: Testosterone Drug: Risedronate |
MedlinePlus related topics: Eating Disorders
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study
Official Title: IGF-1 and Bone Loss in Women Anorexia Nervosa
Expected Total Enrollment: 80
Study start: June 2003
Eligibility
Ages Eligible for Study: 18 Years - 45 Years, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
Exclusion Criteria:
Location
and Contact
Information
More Information
![]() | ||||||||||||||
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |